Overview

Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot

Status:
Active, not recruiting
Trial end date:
2023-03-01
Target enrollment:
0
Participant gender:
All
Summary
This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Rebecca Price
Treatments:
Ketamine
Criteria
Inclusion Criteria:

Participants will:

1. be between the ages of 18 and 65 years

2. be a medical inpatient referred for psychiatric consultation/liaison due to
suicidality

3. possess a level of judgment and understanding sufficient to agree to all procedures
required by the protocol and must sign an informed consent document

4. be deemed an appropriate and reasonable medical candidate for intravenous ketamine by
a physician authorized to prescribe medication to the patient during inpatient
hospitalization

Exclusion Criteria:

1. Presence of current psychotic or autism spectrum disorder or current delirium

2. Use of a Monoamine Oxidase Inhibitor (MAOI) within the previous 2 weeks

3. Current pregnancy or breastfeeding

4. Reading level <5th grade as per WRAT-3 reading subtest

5. Past intolerance or hypersensitivity to ketamine

6. Patients taking any of the following medications: St John's Wort, theophylline,
tramadol, metrizamide

7. Patients who have received ECT in the past 6 months prior to intake

8. Patients at risk for withdrawal related issues (e.g., delirium tremens, severe opiate
withdrawal) or who present with substance-induced psychosis

9. Patients who, based on expressed preference and/or home geographic location, are
deemed by the Psychiatric Consultation/Liaison service to be likely to receive
inpatient psychiatric hospitalization at an alternate location outside of Western
Psychiatric Institute & Clinic